February 2016

The FDA finalized a guidance it originally released in 2012 that is aimed to help industry collect safety data in…

A recent study provides one of the first, if not the first, in-depth, national look at the pace of transition from…

The Eighth Annual Compliance Year-in-Review presentation is now available through Potomac River Partners. This…

The Senate Finance Committee held a hearing focused on the opioid abuse epidemic and its effect on the Medicare system.…

Despite months of hand-wringing and opposition, the Senate overwhelmingly voted to confirm Dr. Robert Califf as the next Food and…

United States House of Representatives member Rosa DeLauro introduced a bill the Responsibility in Drug Advertising Act …

Virginia has joined the list of states with failed attempts at drug price transparency legislation in various states, as…

Pfizer and the United States government reached an "agreement in principle" on February 16, 2016 regarding two…

Recently, the White House released its 2017 Budget through the Office of Management and Budget (OMB). In the Budget, the…

For some time now, both the U.S. Department of Justice ("DOJ") and the Drug Enforcement Administration ("DEA") have…